FibroGen Inc

(FGEN) Trade

By |

Profile

FibroGen is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

Contact Information

Website: www.fibrogen.com
Email: kbergman@fibrogen.com
Main Phone: +1 415 978-1200
Address: 409 Illinois Street
State: CA
City / Town: San Francisco
Country: USA
Postal Code: 94158

Issuer Information

Exchange: NGS
CEO: Thomas B. Neff
Employees: 423
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 37.97 $ -2.96 (-7.23%)
Last Price 37.97 Change $ -2.96 Change % -7.23 Tick N/A
Bid 38.00 Bid Size 1,900.00 Ask 62.00 Ask Size 100.00
Open 41.00 High 42.33 Low 37.64 Prev Close 40.93
Last Trade Volume 961,552 52 Wk Hi 68.55 52 Wk Low 37.64
Market Cap 3.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 84,978,056.00 EPS (TTM) -1.77 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 98 378
Number of Buys 34 87
Number of Sells 64 291
Net Activity -80885 -635883
Last 10 Buys Shares
Gerald Lema 1,000
Last 10 Sell Shares
Jorma Routti 1,000
Pat Cotroneo 1,000
Thomas B. Neff 1,000
Thomas B. Neff 1,000
Thomas B. Neff 1,000
Thomas B. Neff 1,000
Pat Cotroneo 1,000
Thomas B. Neff 1,000
Thomas B. Neff 1,000
Thomas B. Neff 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 89 89 89 89
Low Target Price Estimate 61 61 61 61
Mean Target Price Estimate 75 75 75 75
Standard Deviation 14 14 14 14
Date of Most Recent Estimate 05/10/18 05/10/18 05/10/18 05/10/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 0 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1.4 1.4 1.4